New and Emerging Therapies for GPP
Dr. Bachelez discusses the development of IL-36R inhibitors to treat pustular psoriasis and the necessity for further research.
Dr. Bachelez discusses the development of IL-36R inhibitors to treat pustular psoriasis and the necessity for further research.
Dr. van de Kerkhof reviews the current treatments for generalized pustular psoriasis, there limitations, and the need for improved options.
Dr. Burden discusses how to diagnose and measure the severity of pustular psoriasis.
Dr. Choon discusses the characteristics and course of generalized pustular psoriasis.
Dr. Gudjonsson examines the immunopathogenesis of pustular psoriasis.
Dr. Capon examines the genetic mutation of IL36 and its influence on pustular psoriasis.
Dr. Zheng discusses the challenges in the epidemiology of GPP and the varying disease prevalence by country.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |